Irum Khan MD

Hematologic Oncology

Physician

675 N Saint Clair StSte 20-100Chicago, IL 60611
Phone+1 312-695-1920
Fax+1 312-695-5747

Dr. Khan is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Khan's full profile Already have an account?

Education & Training

McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2009 - 2012
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 2005 - 2008
Aga Khan Medical CollegeClass of 2003

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

IL State Medical License 2009 - 2029
KY State Medical License 2008 - 2010
OH State Medical License 2005 - 2008
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

PTP4A2 promotes leukemogenesis through inhibiting the p53 tumor suppressor signaling pathway in leukemia-initiating cells.
Shiyu Xiao, Michihiro Kobayashi, Yunpeng Bai, Wenjie Cai, Sergio Barajas
Blood Advances. 2026-07-14
NCCN Guidelines® Insights: Myeloproliferative Neoplasms, Version 2.2026.
Aaron T Gerds, Jason Gotlib, Peter Abdelmessieh, Haris Ali, Mariana Castells
Journal of the National Comprehensive Cancer Network. 2026-07-01
Clinical and sociodemographic predictors of intensive care unit admission following chemotherapy in acute myeloid leukemia.
Ivy E Abraham, Garth H Rauscher, Jerry Luo, Sarah Monick, Madelyn Burkart
Haematologica. 2026-07-01

Abstracts/Posters

An Open-Label, Phase 2 Study of KRT-232, a First-in-Class, Oral Small Molecule Inhibitor of MDM2, for the Treatment of Patients with Myelofibrosis (MF) Who Have Previo...
Irum Khan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Role of Racial, Demographic and Socioeconomic Disparities in Treatment Patterns and Outcomes in AML
Irum Khan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

Residence Predictor of Survival Among Black, Hispanic Patients with Acute Myeloid LeukemiaJune 30th, 2022
Mitigating the Effects of Neighborhood Disadvantage in Acute Myeloid Leukemia: Brittany Ragon, MDJanuary 24th, 2024